ARS Pharmaceuticals financial statements

ARS 파머슈티컬스NASDAQ:SPRY · Nasdaq · Healthcare · sector #13
$4.29+5.41%
2026-10-05 close

ARS Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $89M. 2024 operating profit was −$3M.

Reported results

ARS Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q